|
ISCA1P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.08709999949264E-07 |
| Normal-vs-Stage3 |
1.74099999972199E-08 |
| Normal-vs-Stage4 |
3.622300E-03 |
| Stage1-vs-Stage2 |
3.413800E-01 |
| Stage1-vs-Stage3 |
2.938600E-01 |
| Stage1-vs-Stage4 |
9.589500E-02 |
| Stage2-vs-Stage3 |
9.865800E-01 |
| Stage2-vs-Stage4 |
4.121800E-01 |
| Stage3-vs-Stage4 |
4.134400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.90243393155743E-13 |
| Normal-vs-Asian |
6.682100E-02 |
| Caucasian-vs-AfricanAmerican |
2.258800E-01 |
| Caucasian-vs-Asian |
6.800600E-01 |
| AfricanAmerican-vs-Asian |
9.878800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.66577862614758E-12 |
| Male-vs-Female |
2.738200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.03728137190728E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
9.99200722162641E-16 |
| Normal-vs-Extreme_Obese |
2.377800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.773800E-01 |
| Normal_Weight-vs-Obese |
9.215600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.521400E-01 |
| Extreme_Weight-vs-Obese |
2.694600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.119400E-01 |
| Obese-vs-Extreme_Obese |
6.219000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.34349992137106E-10 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.71227484915926E-13 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.168000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.646200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.935180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.029640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.602100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.356150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.85917947703729E-12 |
| Normal-VS-KIRP CIMP |
2.569400E-04 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.203000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.243730E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.810800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.929000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.035900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.843640E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63347113613099E-12 |
| Normal-vs-N1 |
1.87068999999429E-05 |
| Normal-vs-N2 |
1.037580E-01 |
| N0-vs-N1 |
1.407210E-01 |
| N0-vs-N2 |
9.209800E-01 |
| N1-vs-N2 |
5.993600E-01 |
|
|
